Patent 7645747 was granted and assigned to Gilead Sciences on January, 2010 by the United States Patent and Trademark Office.
The invention is related to phosphorus substituted therapeutic agents, compositions containing such phosphorus substituted agents, and therapeutic methods that include the administration of such phosphorus substituted agents, as well as to processes and intermediates useful for preparing such agents.